Table of Contents

company-logo

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Innovation Pharmaceuticals Dividend Announcement

• Innovation Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Innovation Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Innovation Pharmaceuticals Dividend History

Innovation Pharmaceuticals Dividend Yield

Innovation Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Innovation Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Innovation Pharmaceuticals Financial Ratios

P/E ratio-0.07
PEG ratio0.00
P/B ratio0.09
ROE-97.53%
Payout ratio-1.02%
Current ratio0.19
Quick ratio0.19
Cash Ratio0.17

Innovation Pharmaceuticals Dividend FAQ

Does Innovation Pharmaceuticals stock pay dividends?
Innovation Pharmaceuticals does not currently pay dividends to its shareholders.
Has Innovation Pharmaceuticals ever paid a dividend?
No, Innovation Pharmaceuticals has no a history of paying dividends to its shareholders. Innovation Pharmaceuticals is not known for its dividend payments.
Why doesn't Innovation Pharmaceuticals pay dividends?
There are several potential reasons why Innovation Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Innovation Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Innovation Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Innovation Pharmaceuticals a dividend aristocrat?
Innovation Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Innovation Pharmaceuticals a dividend king?
Innovation Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Innovation Pharmaceuticals a dividend stock?
No, Innovation Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Innovation Pharmaceuticals stocks?
To buy Innovation Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Innovation Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.